Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Active, not recruiting · NCT02717156 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, transitional cell carcinoma, urothelial carcinoma | Active, not recruiting | Phase 2 | 2026-06-09 | NCT02717156 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Southern California | 216 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Comprehensive Cancer Centers of Nevada | Las Vegas | United States | 34 |
| LAC+USC Medical Center | Los Angeles | United States | 1 |
| Levine Cancer Institute-Carolinas Medical Center | Charlotte | United States | 1 |
| UC Davis Comprehensive Cancer Center | Sacramento | United States | 23 |
| University of Kansas Cancer Center | Kansas City | United States | 3 |
| University of Virginia Cancer Center | Charlottesville | United States | 206 |
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |
| USC Norris Oncology/Hematology - Newport Beach | Newport Beach | United States | 3 |